LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Начало・Списък с акции・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Затворен

1.28 2.4

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.22

Максимум

1.32

Ключови измерители
By Trading Economics
Приходи	17M -26M
Служители	171
EBITDA	19M -23M

Дивиденти
By Dow Jones
Следващи печалби	26.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-34M 68M
Предишно отваряне	-1.12
Предишно затваряне	1.28

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

1.43 / 1.6 Подкрепа & съпротива

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

19.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19.02.2026 г., 23:39 ч. UTC

Придобивния, сливания и поглъщания

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19.02.2026 г., 23:38 ч. UTC

Печалби

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19.02.2026 г., 23:38 ч. UTC

Печалби

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19.02.2026 г., 23:38 ч. UTC

Печалби

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19.02.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19.02.2026 г., 23:34 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19.02.2026 г., 23:34 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19.02.2026 г., 23:33 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19.02.2026 г., 23:33 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19.02.2026 г., 22:13 ч. UTC

Пазарно говорене

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19.02.2026 г., 22:08 ч. UTC

Печалби

Fairfax Financial 4Q Rev $8.11B >FFH.T

19.02.2026 г., 22:07 ч. UTC

Печалби

Eldorado Gold 4Q EPS $1.19 >ELD.T

19.02.2026 г., 22:06 ч. UTC

Печалби

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19.02.2026 г., 22:05 ч. UTC

Печалби

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19.02.2026 г., 22:05 ч. UTC

Печалби

Eldorado Gold 4Q Rev $577.2M >ELD.T

19.02.2026 г., 22:04 ч. UTC

Печалби

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19.02.2026 г., 22:04 ч. UTC

Печалби

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

19.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

19.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

19.02.2026 г., 21:43 ч. UTC

Печалби

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19.02.2026 г., 21:42 ч. UTC

Придобивния, сливания и поглъщания

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19.02.2026 г., 21:42 ч. UTC

Печалби

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19.02.2026 г., 21:41 ч. UTC

Печалби

Correct: St Barbara 1H Net Loss A$249,000

19.02.2026 г., 21:40 ч. UTC

Печалби

St Barbara 1H Net Loss A$249 Million

19.02.2026 г., 21:39 ч. UTC

Печалби

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19.02.2026 г., 21:37 ч. UTC

Печалби

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19.02.2026 г., 21:37 ч. UTC

Печалби

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Консенсусна оценка

By TipRanks

Продай

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Pliant Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.